G. Michael Iverson
La Jolla Pharmaceutical Company
San Diego
CA 92121
USA
Name/email consistency: medium
- Advances in understanding what we measure when detecting anticardiolipin autoantibodies. Iverson, G.M., Victoria, E.J., Cockerill, K.A., Linnik, M.D. Clin. Chim. Acta (2004)
- The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA. Iverson, G.M., Matsuura, E., Victoria, E.J., Cockerill, K.A., Linnik, M.D. J. Autoimmun. (2002)
- Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies. Iverson, G.M., Reddel, S., Victoria, E.J., Cockerill, K.A., Wang, Y.X., Marti-Renom, M.A., Sali, A., Marquis, D.M., Krilis, S.A., Linnik, M.D. J. Immunol. (2002)
- Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI. Iverson, G.M., Victoria, E.J., Marquis, D.M. Proc. Natl. Acad. Sci. U.S.A. (1998)